Krista Lanctot, PhD, is a professor of psychiatry and pharmacology at the University of Toronto, where her research has focused on optimizing the treatment of neuropsychiatric symptoms associated with illness, including mood changes, apathy, aggression, and cognitive changes.
Dr. Lanctot’s broad experience includes running clinical trials for cognitive and neuropsychiatric symptoms associated with dementia, and her research interests include neuropsychiatric symptoms secondary to central nervous system pathology; neuroimaging, serum protein, lipid and metabolite biomarkers; and medical, dietary and exercise interventions.
Key to her research is determining the underlying neurobiology of neuropsychiatric symptoms, examining predictors of treatment response, using novel pharmacological agents, and carefully considering adverse drug events – all with the goal of providing the background for novel therapies and gaining the ability to predict responses to interventions based on neurobiological subtypes.
